Intuitive Surgical's stock falls on earnings miss
Intuitive Surgical Inc.'s (ISRG) stock tumbled 6% in extended trading Thursday after the health care giant reported quarterly earnings that came up short of analysts' estimates. Intuitive Surgical reported fiscal second-quarter net income of $426 million, or $1.18 a share, compared with net income of $307.8 million, or 85 cents a share, in the year-ago quarter. Adjusted earnings were $1.20 a share. Revenue jumped to $1.76 billion, from $1.5 billion a year ago. Analysts surveyed by FactSet had expected on average net income of $1.33 a share on revenue of $1.74 billion. Shares of Intuitive Surgical have climbed 31% so far this year, while the broader S&P 500 index has increased 18%.
-Jon Swartz
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
07-20-23 1630ET
Copyright (c) 2023 Dow Jones & Company, Inc.-
How Anti-Obesity Drugs Are Innovating the Healthcare Market
-
Why Immigration Has Boosted Job Gains and the Economy
-
What to Invest in During High Inflation
-
Never Mind Market Efficiency: Are the Markets Sensible?
-
Starbucks Stock Could Use a Pick-Me-Up After Big Selloff; Is it a Buy?
-
5 Cheap Stocks to Buy From an Attractive Part of the Market
-
Markets Brief: All Eyes On Inflation
-
5 Things We Learned From the Q1 Earnings Season
-
Baidu Earnings: Advertising Weakness Offset by Continued Growth In Cloud Business
-
Going Into Earnings, Is Target Stock a Buy, a Sell, or Fairly Valued?
-
Walmart Earnings: Low Prices and Strong Digital Presence Drive Market Share Gains
-
After Earnings and a Big Selloff, Is Shopify Stock a Buy, a Sell, or Fairly Valued?
-
Cisco Earnings: Positive Guidance and Splunk Inclusion Align With Our Long-Term Thesis
-
3 Warren Buffett Stocks to Buy After Berkshire Hathaway’s Just-Released 13F Filing
-
Going Into Earnings, Is Nvidia Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is Arista Stock a Buy, a Sell, or Fairly Valued?